A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 126
[Display Entries]
100 entries :
      (Publication year, Descending)
100 entries :
      (Publication year, Ascending)
all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : autoAbs
Long Form : autoantibodies
No. Year Title Co-occurring Abbreviation
2020 A case of anti-BP230 antibody-positive bullous pemphigoid receiving DPP-4 inhibitor. BP, DPP-4i, ELISA
2020 Autoimmune Peripheral Neuropathies and Contribution of Antiganglioside/Sulphatide Autoantibody Testing. IMPN
2020 Clinical features of Japanese systemic sclerosis (SSc) patients negative for SSc-related autoantibodies: A single-center retrospective study. ACA, ANA, anti-RNAP, anti-topo I, IIF, mRSS, SSc
2020 Correlation of IgG autoantibodies against acetylcholine receptors and desmogleins in patients with pemphigus treated with steroid sparing agents or rituximab. AChR, Dsg1, Dsg3, PDAI, PV, SSA, TPO, VZV
2020 Homocysteinylated alpha 1 antitrypsin as an antigenic target of autoantibodies in seronegative rheumatoid arthritis patients. A1AT, ACPA, ELISA, Hcy, RA, RF, SF
2020 Performance evaluation of a commercial line blot assay system for detection of myositis- and systemic sclerosis-related autoantibodies. IIF, IP, LB, SSc
2020 The search for the Holy Grail: autoantigenic targets in primary sclerosing cholangitis associated with disease phenotype and neoplasia. ANCA, GP2, IBD, PR3, PSC
2020 Triterpene glycosides from Blighia welwitschii and evaluation of their antibody recognition capacity in multiple sclerosis. Abs, ELISA, MS
2019 Anti-C1q autoantibodies are frequently detected in patients with systemic sclerosis associated with pulmonary fibrosis. CICs, RA, SjS, SLE, SSc
10  2019 Autoreactive B-lymphocytes in SLE and RA patients: Isolation and characterisation using extractable nuclear and citrullinated antigens bound to immunobeads. ---
11  2019 Blockade Effects of Anti-Interferon- (IFN-) gamma Autoantibodies on IFN-gamma-Regulated Antimicrobial Immunity. NTM
12  2019 Functional neutralization of anti-IFN-gamma autoantibody in patients with nontuberculous mycobacteria infection. IFN, NTM
13  2019 Neutralizing Activity of Anti-interferon-gamma Autoantibodies in Adult-Onset Immunodeficiency Is Associated With Their Binding Domains. AOID, IFN-gamma, mAbs
14  2019 Normal human skin is superior to monkey oesophagus substrate for detection of circulating BP180-NC16A-specific IgG antibodies in bullous pemphigoid. Abs, BP, ELISA, IIF, mAbs, ME, NC16A, NHS
15  2019 Novel Autoantibodies Related to Cell Death and DNA Repair Pathways in Systemic Lupus Erythematosus. SLE
16  2019 Reduction of Total Brain and Cerebellum Volumes Associated With Neuronal Autoantibodies in Patients With APECED. 5-HT, APECED, CSF, GAD, TH
17  2018 Autoantibodies in chronic hepatitis C virus infection: impact on clinical outcomes and extrahepatic manifestations. AMA, ANA, ASMA, HCC, HCV, LKM, SVR
18  2018 Autoantibody Signaling in Pemphigus Vulgaris: Development of an Integrated Model. PV
19  2018 Multiparametric autoantibody profiling of patients with systemic sclerosis in Greece. ANAs, SSc
20  2018 Optimization of an Anti-NMDA Receptor Autoantibody Diagnostic Bioassay. anti-NMDAR, CSF, FEP, FITC, mAb
21  2017 Autoantibodies against the cell surface-associated chaperone GRP78 stimulate tumor growth via tissue factor. TF
22  2017 Autoantibody profiles in autoimmune hepatitis and chronic hepatitis C identifies similarities in patients with severe disease. Abs, AIH, CHC, LKM-1, SMA
23  2017 Crosstalk between Signaling Pathways in Pemphigus: A Role for Endoplasmic Reticulum Stress in p38 Mitogen-Activated Protein Kinase Activation? DSG, ER, p38 MAPK
24  2017 Disease-related autoantibody profile in patients with systemic sclerosis. anti-CENP, CENP-A, CENP-B, dcSSc, ILD, lcSSc, PDGFR, PH, RP, SSc
25  2017 Expression of CD markers' in immune thrombocytopenic purpura: prognostic approaches. ITP, PG
26  2017 Increased immunoreactivity against human cytomegalovirus UL83 in systemic sclerosis. AUs, HCMV, MS, RP11, SSc
27  2017 Next-Generation Autoantibody Testing by Combination of Screening and Confirmation-the CytoBead Technology. ANA, CTDs, IIF, SARD
28  2017 Prevention of lupus nephritis development in NZB/NZW mice by selective blockade of CD28. dsDNA, PD-1, PDL1, SLE
29  2017 Protein array autoantibody profiles to determine diagnostic markers for neuropsychiatric systemic lupus erythematosus. NP
30  2017 Role of Anti-Osteopontin Antibodies in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis. EAE, MS, OPN, OVA, RR
31  2017 The Clinical Features of Myositis-Associated Autoantibodies: a Review. CTD, DM, IIM, PM
32  2016 Autoantibody Profile Differentiates between Inflammatory and Noninflammatory Bullous Pemphigoid. BP, NC16A
33  2016 B cell IFN-gamma receptor signaling promotes autoimmune germinal centers via cell-intrinsic induction of BCL-6. GC, IFN-gammaR, IFNs, SLE
34  2016 Identification of a major epitope by anti-interferon-gamma autoantibodies in patients with mycobacterial disease. EE-IFN-gamma, HLA, IFN, IFN-gammaR
35  2016 IFN-gamma receptor and STAT1 signaling in B cells are central to spontaneous germinal center formation and autoimmunity. IFN-gammaR
36  2016 Induction of autoimmune gastritis by neonatal thymectomy requires autoantibodies and is prevented by anti-FcgammaR antibodies. AIG
37  2016 Longitudinal analysis of antibody profiles against plakins in severe drug eruptions: emphasis on correlation with tissue damage in drug-induced hypersensitivity syndrome and drug reaction with eosinophilia and systemic symptoms. DIHS, DRESS, SJS, TEN
38  2016 Multiplexed autoantigen microarrays identify HLA as a key driver of anti-desmoglein and -non-desmoglein reactivities in pemphigus. Dsg, PV
39  2016 Simultaneous comprehensive multiplex autoantibody analysis for rapidly progressive glomerulonephritis. ANCA, ANCA, GBM, GPA, GPS, HS, IIF, INF, MPA, RPGN, SLE
40  2016 The Laboratory Diagnosis of Autoimmune Encephalitis. CSF
41  2016 Use of the VH6-1 gene segment to code for anti-interleukin-18 autoantibodies in multiple sclerosis. HDs, IL-18, MS, scFvs
42  2016 [Latent autoimmune diabetes of adults (LADA): The informative value of autoantibodies]. GADA, IA-2A, IAA, ICA, LADA, T1DM, ZnT8A
43  2015 Altered IgG autoantibody levels and CD4(+) T cell subsets in lupus-prone Nba2 mice lacking the nuclear progesterone receptor. ERalpha, PR, SLE, Tfh, TREGS
44  2015 Biologic predictors of clinical improvement in rituximab-treated refractory myositis. ---
45  2015 Cell- and nuclear-penetrating anti-dsDNA autoantibodies have multiple arginines in CDR3 of VH and increase cellular level of pERK and Bcl-2 in mesangial cells. ds, mAb, scFv, VH, VL
46  2015 Do associated auto-antibodies influence the outcome of myasthenia gravis after thymectomy? AChR, MG, MGFA
47  2015 Rapid immunochromatographic test for detection of anti-factor XIII A subunit antibodies can diagnose 90 % of cases with autoimmune haemorrhaphilia XIII/13. AH13, ELISA, FXIII, ICT, mAb
48  2015 Second generation analysis of antinuclear antibody (ANA) by combination of screening and confirmatory testing. ANA, dsDNA, ELISA, IIF
49  2014 A rapid method of detecting autoantibody against FcepsilonRIalpha for chronic spontaneous urticaria. ASST, CU, rFcepsilonRIalpha
50  2014 Bacterial ClpB heat-shock protein, an antigen-mimetic of the anorexigenic peptide alpha-MSH, at the origin of eating disorders. alpha-MSH, AN, BED, EDs, Igs
51  2014 Coagulation function and mechanisms in various clinical phenotypes of patients with acquired factorV inhibitors. A-FV, APC
52  2014 Direct proof of the in vivo pathogenic role of the AChR autoantibodies from myasthenia gravis patients. AChR, MG
53  2014 Shared VH1-46 gene usage by pemphigus vulgaris autoantibodies indicates common humoral immune responses among patients. Abs, Dsg3, PV
54  2014 Simultaneous assessment of rotavirus-specific memory B cells and serological memory after B cell depletion therapy with rituximab. MBC, RTX, RV, TT
55  2014 Update on the pathogenesis of bullous pemphigoid: an autoantibody-mediated blistering disease targeting collagen XVII. BP
56  2013 Autoimmune associations and autoantibody screening show focused recognition in patient subgroups with generalized myasthenia gravis. IFT, MG
57  2013 Multi-therapeutic potential of autoantibodies induced by immune complexes trapped on follicular dendritic cells. Ags, FDCs, GCs, IC
58  2013 No evidence of autoimmune disorders in antiretroviral-experienced HIV-1-infected individuals after long-term treatment with raltegravir. RAL
59  2013 Presence of aberrant VH6 domains in anti-interferon-gamma autoantibodies in multiple sclerosis. MS
60  2013 Pristane-induced lupus as a model of human lupus arthritis: evolvement of autoantibodies, internal organ and joint inflammation. PIL, RA
61  2012 Acetylcholine receptor-induced experimental myasthenia gravis: what have we learned from animal models after three decades? AChR, EAMG, MG
62  2012 Altered patterns of epigenetic changes in systemic lupus erythematosus and auto-antibody production: is there a link? RNP, SLE
63  2012 Anti-cytokine autoantibodies in autoimmune diseases. ---
64  2012 Anti-neuropeptide Y plasma immunoglobulins in relation to mood and appetite in depressive disorder. NPY
65  2012 Autoantibodies directed against labile epitopes on cell surface proteins in autoimmune disease patients: proposal of a novel ELISA for the detection of anti-endothelial cell antibodies. Abs, AECAs, Ags, auto-Ags, CSP-ELISA, EC, HUVECs, MCTD, NeuAvi, SDS-PAGE, SLE, SSc
66  2012 Bilateral paraneoplastic optic neuropathy and unilateral retinal compromise in association with prostate cancer: a differential diagnostic challenge in a patient with unexplained visual loss. CAON, CAR, CRAO, ERGs, GVFs, IVFA, OCT, PVEPs
67  2012 Combined treatment with immunoadsorption and rituximab leads to fast and prolonged clinical remission in difficult-to-treat pemphigus vulgaris. CS, IA, PV, RTX
68  2012 Immunoglobulin gene repertoire in ocular adnexal lymphomas: hints on the nature of the antigenic stimulation. Cp, Ig, OAMZL
69  2012 Pathogenic role of anti-M3 muscarinic acetylcholine receptor immune response in Sjogren's syndrome. AIS, SGs, SS
70  2012 Pregnancy outcomes in patients with systemic autoimmunity. SLE
71  2012 T-cell recognition of acetylcholine receptor provides a reliable means for monitoring autoimmunity to acetylcholine receptor in antibody-negative myasthenia gravis patients. AChR, HLA, MG
72  2012 [Comparative analysis of the serum level of autoantibodies as a diagnostic tool of myocardial inflammatory diseases]. AMI, CEG
73  2011 Amplified B lymphocyte CD40 signaling drives regulatory B10 cell expansion in mice. ---
74  2011 Autoantibodies reacting with vasopressin and oxytocin in relation to cortisol secretion in mild and moderate depression. HPA, MADRS, OT, VP
75  2011 Galanin and alpha-MSH autoantibodies in cerebrospinal fluid of patients with Alzheimer's disease. AD, alpha-MSH, BMI, CSF, MMSE
76  2011 Ghrelin reactive autoantibodies in restrictive anorexia nervosa. AN, Ig
77  2011 Identification of periplakin as a new target for autoreactivity in idiopathic pulmonary fibrosis. IPF, PPL
78  2011 Mucocutaneous candidiasis and autoimmunity against cytokines in APECED and thymoma patients: clinical and pathogenetic implications. AIRE, APECED, CMC, mTECs, ts-ags
79  2010 Autoantibodies against IL-17A, IL-17F, and IL-22 in patients with chronic mucocutaneous candidiasis and autoimmune polyendocrine syndrome type I. APS I, CMC, IFN, IL
80  2010 Baseline autoantibody profiles predict normalization of complement and anti-dsDNA autoantibody levels following rituximab treatment in systemic lupus erythematosus. RBP, RTX, SLE
81  2010 Differential influence of anticancer treatments and angiogenesis on the seric titer of autoantibody used as tumor and metastasis biomarker. GRP78
82  2010 Inborn errors of mucocutaneous immunity to Candida albicans in humans: a role for IL-17 cytokines? CMC
83  2010 Non-organ-specific and anti-endothelial antibodies in relation to CMV infection and acute rejection in renal transplant recipients. CMV, NOSA
84  2010 Psychopathological and personality features in primary Sjogren's syndrome--associations with autoantibodies to neuropeptides. alpha-MSH, HCs, pSS
85  2010 Recent approaches to the development of antigen-specific immunotherapies for myasthenia gravis. AChR, MG, NMJ
86  2010 Serum anti-PDIK1L autoantibody as a novel marker for endometriosis. ---
87  2010 TNF blocker drugs modulate human TNF-alpha-converting enzyme pro-domain shedding induced by autoantibodies. SGEC, TACE
88  2009 A lupus-susceptibility C57BL/6 locus on chromosome 3 (Sle18) contributes to autoantibody production in 129 mice. ---
89  2009 Anti-melanocortin-4 receptor autoantibodies in obesity. MC4R
90  2009 Autoantibodies in autoimmune polyglandular syndrome type I patients react with major brain neurotransmitter systems. AADC, GABA, GAD, TH, TPH
91  2009 Autoantibodies to oxidized low density lipoprotein in relation with coronary artery disease. CAD, ICs, oxLDL
92  2009 Identification of anti-alpha-enolase autoantibody as a novel serum marker for endometriosis. ---
93  2009 Regulation of feeding and anxiety by alpha-MSH reactive autoantibodies. alpha-MSH
94  2009 [Autoantibodies in systemic sclerosis: clinical interest and diagnosis approach]. ANA, SSc
95  2008 Oxidation of LDL and its clinical implication. apoB, APS, CRP, LDL, oxLDL, SLE
96  2008 Serum autoantibody to sideroflexin 3 as a novel tumor marker for oral squamous cell carcinoma. SFXN3
97  2008 TREX1 polymorphisms associated with autoantibodies in patients with systemic lupus erythematosus. SLE, SNPs
98  2007 Autoantibodies in nonautoimmune individuals during infections. ANA, ASCA, TPO
99  2006 Aggressive behavior linked to corticotropin-reactive autoantibodies. alpha-MSH, IgG, IgM
100  2006 Autoantibody-mediated demyelination depends on complement activation but not activatory Fc-receptors. EAE, FcR, Ig, MS